Raymond V - Search Results

1

Phase II study of 4-demethoxydaunorubicin in patients with adenocarcinoma of the upper gastrointestinal tract.

Einzig A, Kelsen D, Cheng E, Sordillo P, Raymond V, Magill G. Einzig A, et al. Among authors: raymond v. Cancer Treat Rep. 1984 Nov;68(11):1415-6. Cancer Treat Rep. 1984. PMID: 6594197 No abstract available.

2

Phase II trial of idarubicin in patients with pancreatic cancer.

Mittelman A, Magill GB, Raymond V, Sternberg CN, Cheng EW, Sordillo PB, Young CW. Mittelman A, et al. Among authors: raymond v. Cancer Treat Rep. 1987 Jun;71(6):657-8. Cancer Treat Rep. 1987. PMID: 3472656 No abstract available.

3

Phase II study of 4-demethoxydaunorubicin in advanced ovarian carcinoma.

Hakes TB, Daghestani AN, Dougherty JB, Weiselberg L, Raymond V. Hakes TB, et al. Among authors: raymond v. Cancer Treat Rep. 1985 May;69(5):559-60. Cancer Treat Rep. 1985. PMID: 3859369 No abstract available.

4

Phase II evaluation of orally administered idarubicin in patients with advanced breast cancer.

Casper ES, Raymond V, Hakes TB, Currie VE, Kaufman RJ. Casper ES, et al. Among authors: raymond v. Cancer Treat Rep. 1987 Dec;71(12):1289-90. Cancer Treat Rep. 1987. PMID: 3480045 No abstract available.

5

Phase II study of idarubicin in advanced endometrial carcinoma.

Hakes TB, Raymond V. Hakes TB, et al. Among authors: raymond v. Cancer Treat Rep. 1987 May;71(5):535-6. Cancer Treat Rep. 1987. PMID: 3471330 No abstract available.

6

Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancer.

Leitner SP, Casper ES, Hakes TB, Kaufman RJ, Winn RJ, Scoppetuolo M, Raymond V, Geller NL, Young CW. Leitner SP, et al. Among authors: raymond v. Cancer Treat Rep. 1985 Nov;69(11):1319-20. Cancer Treat Rep. 1985. PMID: 4092194

7

Phase II trial of esorubicin in patients with advanced colorectal carcinoma.

Fiore J, Kemeny N, Raymond V, Young C. Fiore J, et al. Among authors: raymond v. Cancer Treat Rep. 1986 Oct;70(10):1241-2. Cancer Treat Rep. 1986. PMID: 3530453 Clinical Trial. No abstract available.

8

Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.

Young CW, Raymond V. Young CW, et al. Among authors: raymond v. Cancer Treat Rep. 1986 Jan;70(1):51-63. Cancer Treat Rep. 1986. PMID: 2935251 Review. No abstract available.

9

Phase I and clinical pharmacological evaluation of 4'-deoxydoxorubicin in patients with advanced cancer.

Stanton GF, Raymond V, Wittes RE, Schulman P, Budman D, Baratz R, Williams L, Petroni GR, Geller NL, Hancock C, et al. Stanton GF, et al. Among authors: raymond v. Cancer Res. 1985 Apr;45(4):1862-8. Cancer Res. 1985. PMID: 3978646

10

4-demethoxydaunorubicin (idarubicin) in combination with 1-beta-D-arabinofuranosylcytosine in the treatment of relapsed or refractory acute leukemia.

Berman E, Raymond V, Daghestani A, Arlin ZA, Gee TS, Kempin S, Hancock C, Williams L, Stevens YW, Clarkson BD, et al. Berman E, et al. Among authors: raymond v. Cancer Res. 1989 Jan 15;49(2):477-81. Cancer Res. 1989. PMID: 2910465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

335 results

Search Page

Filters